Cargando…

Systemic and functional effects of continuous azithromycin treatment in patients with severe chronic obstructive pulmonary disease and frequent exacerbations

BACKGROUND: Continuous treatment with azithromycin may lead to fewer acute exacerbations of chronic obstructive pulmonary disease (AECOPD), but little is known of its impact on systemic and functional outcomes in real-life settings. METHODS: This was a multicenter prospective observational study of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuevas, Ester, Huertas, Daniel, Montón, Concepción, Marin, Alicia, Carrera-Salinas, Anna, Pomares, Xavier, García-Nuñez, Marian, Martí, Sara, Santos, Salud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10406447/ https://www.ncbi.nlm.nih.gov/pubmed/37554497 http://dx.doi.org/10.3389/fmed.2023.1229463

Ejemplares similares

Long-term azithromycin therapy in patients with severe COPD and repeated exacerbations
por: Pomares, Xavier, et al.
Publicado: (2011)

Genetic Adaptation and Acquisition of Macrolide Resistance in Haemophilus spp. during Persistent Respiratory Tract Colonization in Chronic Obstructive Pulmonary Disease (COPD) Patients Receiving Long-Term Azithromycin Treatment
por: Carrera-Salinas, Anna, et al.
Publicado: (2022)

Nebulized Colistin And Continuous Cyclic Azithromycin In Severe COPD Patients With Chronic Bronchial Infection Due To Pseudomonas aeruginosa: A Retrospective Cohort Study
por: Montón, Concepción, et al.
Publicado: (2019)

Long-Term Azithromycin Maintenance Treatment in Patients with Frequent Exacerbations of Chronic Obstructive Pulmonary Disease
por: Talman, Sander, et al.
Publicado: (2021)

C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity
por: Gallego, Miguel, et al.
Publicado: (2016)

Treatment of patients with COPD and recurrent exacerbations: the role of infection and inflammation
por: Santos, Salud, et al.
Publicado: (2016)

Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: characterization and risk factors
por: Gallego, Miguel, et al.
Publicado: (2014)

The Respiratory Microbiome in Cystic Fibrosis: Compartment Patterns and Clinical Relationships in Early Stage Disease
por: Garcia-Nuñez, Marian, et al.
Publicado: (2020)

Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease
por: Ahmadian, Safa, et al.
Publicado: (2022)

Functional Metagenomics of the Bronchial Microbiome in COPD
por: Millares, Laura, et al.
Publicado: (2015)

Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease
por: Wedzicha, Jadwiga A, et al.
Publicado: (2013)

Frequent Outpatient Visits Prevent Exacerbation of Chronic Obstructive Pulmonary Disease
por: Park, Hye Jung, et al.
Publicado: (2020)

Plasma Proteomics Study Between the Frequent Exacerbation and Infrequent Exacerbation Phenotypes of Chronic Obstructive Pulmonary Disease
por: Yang, Chengyu, et al.
Publicado: (2023)

Use of azithromycin in the treatment of acute exacerbations of COPD
por: Milstone, Aaron P
Publicado: (2008)

Azithromycin: Exacerbation of diaphragm hemiparesis: case report
Publicado: (2020)

Some Pneumococcal Serotypes Are More Frequently Associated with Relapses of Acute Exacerbations in COPD Patients
por: Domenech, Arnau, et al.
Publicado: (2013)

Impact of acute exacerbations on platelet reactivity in chronic obstructive pulmonary disease patients
por: Muñoz-Esquerre, Mariana, et al.
Publicado: (2017)

Frequent utilization of the emergency department for acute exacerbation of chronic obstructive pulmonary disease
por: Hasegawa, Kohei, et al.
Publicado: (2014)

Antibody deficiency in patients with frequent exacerbations of Chronic Obstructive Pulmonary Disease (COPD)
por: McCullagh, Brian N., et al.
Publicado: (2017)

Chronic Obstructive Pulmonary Disease with Frequent Exacerbator Phenotype: What is Different in these Patients?
por: Uslu, Berat, et al.
Publicado: (2022)

Sputum-Rheology-Based Strategy for Guiding Azithromycin Prescription in COPD Patients with Frequent Exacerbations: A Randomized, Controlled Study (“COPD CARhE”)
por: Charriot, Jeremy, et al.
Publicado: (2023)

Roflumilast in Severely Ill Patients with Chronic Obstructive Pulmonary Disease with Frequent Exacerbations: Risk of Pneumonia Hospitalization and Severe Exacerbations
por: Alispahic, Imane Achir, et al.
Publicado: (2020)

Relationship between Periodontitis-Related Antibody and Frequent Exacerbations in Chronic Obstructive Pulmonary Disease
por: Takahashi, Tamaki, et al.
Publicado: (2012)

Time course of inflammation resolution in patients with frequent exacerbations of chronic obstructive pulmonary disease
por: Chang, Chun, et al.
Publicado: (2014)

Exome and Sputum Microbiota as Predictive Markers of Frequent Exacerbations in Chronic Obstructive Pulmonary Disease
por: Su, Linfan, et al.
Publicado: (2022)

Azithromycin: The Holy Grail to Prevent Exacerbations in Chronic Respiratory Disease?
por: Welte, Tobias
Publicado: (2019)

Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori
por: Ra, Seung Won, et al.
Publicado: (2017)

1297. Azithromycin vs Beta Lactams in Acute Exacerbations of COPD
por: Kale-Pradhan, Pramodini, et al.
Publicado: (2021)

“Frequent exacerbator” is a phenotype of poor prognosis in Japanese patients with chronic obstructive pulmonary disease
por: Tomioka, Ryusuke, et al.
Publicado: (2016)

A search for covert precipitating clinical parameters in frequent exacerbators of chronic obstructive pulmonary disease
por: Bhatia, Ankit, et al.
Publicado: (2016)

Clinical and pulmonary functions profiling of patients with chronic obstructive pulmonary disease experiencing frequent acute exacerbations
por: Gupta, Prem Parkash, et al.
Publicado: (2018)

Investigation on the Pathological Mechanism of Frequent Exacerbators With Chronic Obstructive Pulmonary Disease Based on the Characteristics of Respiratory Flora
por: Ke, Li, et al.
Publicado: (2022)

The Clinical Characteristics and Outcomes in Non-Frequent Exacerbation Patients with Chronic Obstructive Pulmonary Disease in the Chinese Population
por: Liu, Dan, et al.
Publicado: (2023)

Sputum PGP is reduced by azithromycin treatment in patients with COPD and correlates with exacerbations
por: O'Reilly, Philip J, et al.
Publicado: (2013)

Azithromycin and Tobramycin Therapy in Cystic Fibrosis Pulmonary Exacerbations: Less Is More?
por: Thornton, Christina, et al.
Publicado: (2021)

Azithromycin Versus Beta-lactams in Hospitalized Patients with Acute Exacerbations of COPD
por: Baalbaki, Nour, et al.
Publicado: (2022)

Azithromycin-Induced Liver Injury in an Asthma Exacerbation Patient With Autoimmune Features
por: Liang, Richard, et al.
Publicado: (2022)

Clinical Characterization of the Frequent Exacerbator Phenotype in Asthma
por: Sprio, Andrea Elio, et al.
Publicado: (2020)

Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations
por: Lin, Chieh-Mo, et al.
Publicado: (2020)

Do frequent moderate exacerbations contribute to progression of chronic obstructive pulmonary disease in patients who are ex-smokers?
por: Dreyse, Jorge, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1a6p2a7u3ttcdpofq4m48v5l4n